Ibrutinib 420mg tablets
NHS hospitals in England used £60,503,526 of indicative cost of Ibrutinib 420mg tablets in the 12 months to July 2026, about 0.2% of all hospital medicines spend. That is down 13.4% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Ibrutinib 420mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Ibrutinib 420mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Hull And East Yorkshire Hpls Nhs Trust | £1,780,886 |
| Norfolk & Norwich University Hpl Nhs Trt | £1,712,668 |
| East Sussex Healthcare Nhs Trust | £1,654,720 |
| Western Sussex Hospitals Nhs Found Trust | £1,330,491 |
| University College London Foundation Tr | £1,267,331 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,253,381 |
| Oxford University Hospitals Nhs Ft | £1,161,094 |
| South Tyneside And Sunderland Nhs Ft | £1,122,463 |
| University Hospitals Dorset Nhs Ft | £1,109,585 |
| The Christie Nhs Foundation Trust | £1,085,977 |
The primary-care picture
Ibrutinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Ibrutinib medicine page.